John J Callanan Selected Research

John J Callanan Research Topics

Disease

6	Serotonin Syndrome (Syndrome, Serotonin) 01/2019 - 04/2015
4	Inflammation (Inflammations) 06/2014 - 05/2009
3	Necrosis 01/2013 - 04/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 02/2015
2	Colitis 05/2020 - 01/2008
2	Endometritis 01/2019 - 10/2015
2	Infections 06/2015 - 01/2012
2	Persistent Infection 06/2015 - 11/2008
1	Melanosis (Freckles) 01/2023
1	Alcoholism (Alcohol Abuse) 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Influenza in Birds (Avian Flu) 05/2019
1	Delirium 01/2019
1	Hallucinations (Hallucination) 01/2019
1	Uterine Diseases (Endometrial Disease) 01/2019
1	Hyperthyroidism 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 09/2015
1	Leptospirosis 06/2015
1	Weight Loss (Weight Reduction) 02/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2015
1	Glioblastoma (Glioblastoma Multiforme) 08/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2012
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2012
1	Neoplasms (Cancer) 02/2012
1	Cholestasis 04/2011
1	Hypertrophy 04/2011
1	Hyperplasia 04/2011
1	Virus Diseases (Viral Diseases) 05/2010
1	Atopic Dermatitis (Atopic Eczema) 05/2009
1	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 05/2009
1	Eczema 05/2009
1	Asthma (Bronchial Asthma) 05/2009
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2008
1	Multiple Organ Failure (MODS) 01/2008
1	Central Nervous System Infections (Central Nervous System Infection) 08/2005
1	Muscular Dystrophies (Muscular Dystrophy) 02/2004

Drug/Important Bio-Agent (IBA)

5	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2019 - 04/2015
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2008
3	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 01/2017
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2015 - 01/2012
3	CytokinesIBA 01/2013 - 05/2010
2	Biomarkers (Surrogate Marker)IBA 10/2015 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2013 - 01/2012
2	Interleukin-8 (Interleukin 8)IBA 01/2013 - 01/2012
1	CeroidIBA 01/2023
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	laminaranIBA 05/2020
1	Acetates (Acetic Acid Esters)FDA Link 05/2020
1	Volatile Fatty AcidsIBA 05/2020
1	AntibodiesIBA 05/2019
1	SaltsIBA 01/2019
1	ProteomeIBA 01/2019
1	Synthetic CathinoneIBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	paraform (paraformaldehyde)IBA 09/2015
1	Oligonucleotide ProbesIBA 09/2015
1	Peptides (Polypeptides)IBA 09/2015
1	Amyloid (Amyloid Fibrils)IBA 09/2015
1	Neuroprotective AgentsIBA 02/2015
1	Free RadicalsIBA 02/2015
1	Kainic Acid (Kainate)IBA 02/2015
1	Thyrotropin-Releasing Hormone Receptors (Thyrotropin Releasing Hormone Receptor)IBA 02/2015
1	OilsIBA 06/2014
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2013
1	InterleukinsIBA 01/2013
1	DefensinsIBA 01/2013
1	Toll-Like Receptor 4IBA 01/2013
1	NF-kappa B p50 SubunitIBA 01/2013
1	HaptoglobinsIBA 01/2013
1	Antimicrobial PeptidesIBA 01/2013
1	ChemokinesIBA 01/2013
1	CaspasesIBA 01/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2012
1	Cytokine Receptors (Cytokine Receptor)IBA 09/2012
1	Claudin-5IBA 05/2012
1	ADPM06IBA 02/2012
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2012
1	alovudineIBA 02/2012
1	Membrane Transport Proteins (Biological Pump)IBA 04/2011
1	BilirubinIBA 04/2011
1	Immunoglobulin E (IgE)IBA 05/2009
1	AntigensIBA 05/2009
1	Filaggrin ProteinsIBA 05/2009
1	EndotoxinsIBA 01/2008
1	Phenobarbital (Luminal)FDA Link 01/2008
1	NF-kappa B (NF-kB)IBA 01/2008
1	Dextrans (Dextran)FDA Link 01/2008
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2008
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2008
1	oxalylglycineIBA 01/2008
1	DystrophinIBA 02/2004

Therapy/Procedure

3	Therapeutics 01/2023 - 08/2005
1	Electrodes (Electrode) 01/2021
1	Induced Hypothermia 01/2016
1	Photochemotherapy (Photodynamic Therapy) 02/2012